Gilbertson MW - Search Results

1

Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia.

Gilbertson MW, van Kammen DP. Gilbertson MW, et al. Biol Psychiatry. 1997 Oct 1;42(7):585-95. doi: 10.1016/S0006-3223(96)00435-0. Biol Psychiatry. 1997. PMID: 9376455 Clinical Trial.

2

CSF chromogranin A-like immunoreactivity in schizophrenia: relationships with REM latency and slow wave sleep.

van Kammen DP, O'Connor DT, Neylan TC, Mouton A, Gurklis JA, Gilbertson MW, Peters JL. van Kammen DP, et al. Among authors: gilbertson mw. Psychiatry Res. 1992 Apr;42(1):53-63. doi: 10.1016/0165-1781(92)90038-5. Psychiatry Res. 1992. PMID: 1603881

3

Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia.

van Kammen DP, Kelley ME, Gurklis JA, Gilbertson MW, Yao JK, Peters JL. van Kammen DP, et al. Among authors: gilbertson mw. Arch Gen Psychiatry. 1995 Aug;52(8):673-8. doi: 10.1001/archpsyc.1995.03950200063015. Arch Gen Psychiatry. 1995. PMID: 7543265

4

CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study.

van Kammen DP, Guidotti A, Neylan T, Guarneri P, Kelley ME, Gurklis J, Gilbertson MW, Peters JL, Costa E. van Kammen DP, et al. Among authors: gilbertson mw. Eur Arch Psychiatry Clin Neurosci. 1994;244(4):216-22. doi: 10.1007/BF02190401. Eur Arch Psychiatry Clin Neurosci. 1994. PMID: 7888420

5

Electroencephalographic sleep in clinically stable schizophrenic patients: two-weeks versus six-weeks neuroleptic-free.

Nofzinger EA, van Kammen DP, Gilbertson MW, Gurklis JA, Peters JL. Nofzinger EA, et al. Among authors: gilbertson mw. Biol Psychiatry. 1993 Jun 1-15;33(11-12):829-35. doi: 10.1016/0006-3223(93)90024-8. Biol Psychiatry. 1993. PMID: 8104041 Clinical Trial.

6

CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures.

van Kammen DP, Kelley ME, Gilbertson MW, Gurklis J, O'Connor DT. van Kammen DP, et al. Among authors: gilbertson mw. Am J Psychiatry. 1994 Mar;151(3):372-8. doi: 10.1176/ajp.151.3.372. Am J Psychiatry. 1994. PMID: 8109645

7

Memory and plasma HVA changes in schizophrenia: are they episode markers?

Gilbertson MW, Yao JK, van Kammen DP. Gilbertson MW, et al. Biol Psychiatry. 1994 Feb 1;35(3):203-6. doi: 10.1016/0006-3223(94)91153-3. Biol Psychiatry. 1994. PMID: 8173021 Clinical Trial. No abstract available.

8

CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships.

van Kammen DP, Guidotti A, Kelley ME, Gurklis J, Guarneri P, Gilbertson MW, Yao JK, Peters J, Costa E. van Kammen DP, et al. Among authors: gilbertson mw. Biol Psychiatry. 1993 Oct 15;34(8):515-22. doi: 10.1016/0006-3223(93)90193-h. Biol Psychiatry. 1993. PMID: 8274578 Clinical Trial.

9

Predicting haloperidol treatment response in chronic schizophrenia.

van Kammen DP, Kelley ME, Yao JK, Gilbertson MW, Gurklis JA, Inosaka T, Saito H, Peters JL, Sato M. van Kammen DP, et al. Among authors: gilbertson mw. Psychiatry Res. 1996 Aug 30;64(1):47-58. doi: 10.1016/0165-1781(96)02906-x. Psychiatry Res. 1996. PMID: 8888364 Clinical Trial.

10

Predicting duration of clinical stability following haloperidol withdrawal in schizophrenic patients.

van Kammen DP, Kelley ME, Gurklis JA, Gilbertson MW, Yao JK, Condray R, Peters JL. van Kammen DP, et al. Among authors: gilbertson mw. Neuropsychopharmacology. 1996 Apr;14(4):275-83. doi: 10.1016/0893-133X(95)00135-Z. Neuropsychopharmacology. 1996. PMID: 8924195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters